Literature DB >> 8062604

Muscle fiber composition and capillary density in women and men with NIDDM.

P Mårin1, B Andersson, M Krotkiewski, P Björntorp.   

Abstract

OBJECTIVE: To determine whether muscle fiber composition and capillary density differed between diabetic and nondiabetic subjects. RESEARCH DESIGN AND METHODS: Muscle fiber composition and capillary density were determined in biopsies from women and men with non-insulin-dependent diabetes mellitus (NIDDM) and compared with those of control subjects matched for gender, age, obesity, and the waist-to-hip ratio, which are all factors known to influence muscle morphology.
RESULTS: Patients with NIDDM, as well as control subjects with abdominal obesity and insulin resistance, showed the same abnormalities in muscle morphology, namely, a low percentage of type I fibers, elevated type II (particularly type IIB) fibers, and a low capillary density. These changes correlated closely with insulin concentrations in both diabetic and nondiabetic groups.
CONCLUSIONS: Recent information suggests that insulin may regulate myosin synthesis in muscle in the direction of the changes observed. Therefore, it is possible that muscle fiber composition abnormalities in insulin-resistant conditions are secondary to hyperinsulinemia. However, the low capillary density, hypothetically, may contribute to insulin resistance.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8062604     DOI: 10.2337/diacare.17.5.382

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  87 in total

1.  Validation of a simple, rapid, and economical technique for distinguishing type 1 and 2 fibres in fixed and frozen skeletal muscle.

Authors:  W M H Behan; D W Cossar; H A Madden; I C McKay
Journal:  J Clin Pathol       Date:  2002-05       Impact factor: 3.411

Review 2.  Effect of diabetes mellitus on pharmacokinetic and pharmacodynamic properties of drugs.

Authors:  Miroslav Dostalek; Fatemeh Akhlaghi; Martina Puzanovova
Journal:  Clin Pharmacokinet       Date:  2012-08-01       Impact factor: 6.447

Review 3.  Type 2 diabetes mellitus and cardiovascular exercise performance.

Authors:  Judith G Regensteiner
Journal:  Rev Endocr Metab Disord       Date:  2004-08       Impact factor: 6.514

4.  31P MR spectroscopy and in vitro markers of oxidative capacity in type 2 diabetes patients.

Authors:  S F E Praet; H M M De Feyter; R A M Jonkers; K Nicolay; C van Pul; H Kuipers; L J C van Loon; J J Prompers
Journal:  MAGMA       Date:  2006-12-19       Impact factor: 2.310

Review 5.  Invited review: activity-induced angiogenesis.

Authors:  Stuart Egginton
Journal:  Pflugers Arch       Date:  2008-08-13       Impact factor: 3.657

6.  Hepatic autophagy is suppressed in the presence of insulin resistance and hyperinsulinemia: inhibition of FoxO1-dependent expression of key autophagy genes by insulin.

Authors:  Hui-Yu Liu; Jianmin Han; Sophia Y Cao; Tao Hong; Degen Zhuo; Jianbo Shi; Zhenqi Liu; Wenhong Cao
Journal:  J Biol Chem       Date:  2009-09-16       Impact factor: 5.157

Review 7.  Mitochondrial fitness and insulin sensitivity in humans.

Authors:  J Szendroedi; M Roden
Journal:  Diabetologia       Date:  2008-09-19       Impact factor: 10.122

8.  Early life nutrition modulates muscle stem cell number: implications for muscle mass and repair.

Authors:  Melissa Woo; Elvira Isganaitis; Massimiliano Cerletti; Connor Fitzpatrick; Amy J Wagers; Jose Jimenez-Chillaron; Mary Elizabeth Patti
Journal:  Stem Cells Dev       Date:  2011-03-09       Impact factor: 3.272

9.  Insulin resistance in relatives of NIDDM patients: the role of physical fitness and muscle metabolism.

Authors:  B Nyholm; A Mengel; S Nielsen; C Skjaerbaek; N Møller; K G Alberti; O Schmitz
Journal:  Diabetologia       Date:  1996-07       Impact factor: 10.122

Review 10.  Signaling mechanisms in skeletal muscle: acute responses and chronic adaptations to exercise.

Authors:  Katja S C Röckl; Carol A Witczak; Laurie J Goodyear
Journal:  IUBMB Life       Date:  2008-03       Impact factor: 3.885

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.